SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)
Demographics (2)
- AGE - Subject age at enrollment (phv00572243.v1.p1)
- SEX - Biological sex (phv00572237.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for MPNST (phv00572241.v1.p1)
Other (25)
- ANALYTE_TYPE - Analyte type (phv00572254.v1.p1)
- BODY_SITE - Body site from which sample was collected (phv00572253.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body. (phv00572236.v1.p1)
- HISTOLOGICAL_TYPE - Histological diagnosis (phv00572256.v1.p1)
- IS_TUMOR - Tumor status (phv00572255.v1.p1)
- LOCALIZED_METASTATIC - Localized or metastic disease. (phv00572257.v1.p1)
- Met_sites - Sites of metastases at time of study enrollment. (phv00572251.v1.p1)
- Metastases_at_dx - Presense of metastases at initial diagnosis (phv00572249.v1.p1)
- Metastases_at_enrollment - Presense of metastases at time of study enrollment (phv00572250.v1.p1)
- MPNST_Subtype - Primary tumor in soft tissue, bone, or both (phv00572244.v1.p1)
- NEW_LESIONS - New lesions in interval since last imaging (phv00572262.v1.p1)
- NF1_STATUS - Is the tumor sporadic or associated with NF1 (phv00572242.v1.p1)
- Post-operative_Recurrance - Recurrence status post-resection of priamry tumor (phv00572248.v1.p1)
- Primary_Tumor_Location - Anatomic location of primary tumor (phv00572245.v1.p1)
- Primary_Tumor_Resected - If primary tumor had been resected pre-study enrollment (phv00572246.v1.p1)
- Resection_Outcome - Residual disease status post-resection of primary tumor (phv00572247.v1.p1)
- SAMPLE_ID - Sample ID (phv00572252.v1.p1)
- SAMPLE_ID - Sample ID (phv00572239.v1.p1)
- SLD - Sum of longest diameters (SLD) per RECIST criteria (phv00572260.v1.p1)
- SUBJECT_ID - Subject ID (phv00572240.v1.p1)
- SUBJECT_ID - Subject ID (phv00572235.v1.p1)
- SUBJECT_ID - Subject ID (phv00572238.v1.p1)
- SUL - SUV normalized by lean body mass (SUL) (phv00572261.v1.p1)
- TREATMENT_CYCLE - Cycle of treatment (phv00572259.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00572258.v1.p1)